Clinical Trial Update: Efficacy of DA-5204 on Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating DA-5204 for esophageal disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Disease

Drugs mentioned

• DA-5204

Snippet

Sponsor: Seoul National University Hospital | Conditions: Esophageal Disease | Phase 3 | Status: COMPLETED